# Aytu Biopharma, Inc: Form 8-K, filed Nov 14, 2023

- Company: [Aytu Biopharma, Inc](/companies/aytu.md) (CIK 1385818)
- Form: 8-K
- Filed: 2023-11-14
- Accepted by EDGAR: Nov 14, 2023, 16:10 ET
- Period: 2023-11-14
- Accession: 0001558370-23-019023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1385818/000155837023019023/aytu-20231114x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1385818/000155837023019023/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1385818/000155837023019023/aytu-20231114x8k.htm

Filed Nov 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-019023. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.